Foreign portfolio investors can now invest up to 49 per cent of the paid-up capital of Glenmark Pharmaceuticals under the portfolio investment scheme, the RBI said on Monday. FIIs now hold 34.71 per cent stake in the pharma major. FIIs, in January-March, raised their stake to 34.71 per cent from 34.62 per cent in the preceding quarter. In December, it had received shareholder nod for hiking FII holding.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.